Atezolizumab Reference: HY-P9904 Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
Detumomab Reference: HY-P99851 Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).
Melredableukin alfa Reference: HY-P99728 Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis.
Phospho FAK Antibody Panel Reference: ARG30203 Phospho FAK antibody; Phospho Focal adhesion kinase antibody; FAK antibody; FAK phospho (Tyr925) antibody; FAK phospho (Tyr397) antibody; FAK phospho (Tyr576 / Tyr577) antibody
Amlitelimab Reference: HY-P99434 Alvircept sudotox is an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb). Alvircept sudotox inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis.
Garadacimab Reference: HY-P99631 Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.
Ipafricept Reference: HY-P99667 Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt ligand. Ipafricept shows solid tumor inhibition activity, with well tolerance.